Bimekizumab in Biologics-Refractory Psoriatic Arthritis: A Real-Life Analysis from a Combined Dermatology-Rheumatology Clinic

Alen Zabotti1 Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy

https://orcid.org/0000-0002-0573-464X View further author information

Nicola Cabas1 Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universitaria Friuli Centrale, Udine, ItalyView further author information

Ivan Giovannini1 Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy

https://orcid.org/0000-0002-1110-2518 View further author information

Silvia Guella1 Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universitaria Friuli Centrale, Udine, ItalyView further author information

Lorenzo Cereser2 Department of Medicine, Institute of Radiology, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy

https://orcid.org/0000-0003-4480-8872 View further author information

Chiara Zuiani2 Department of Medicine, Institute of Radiology, Azienda sanitaria universitaria Friuli Centrale, Udine, ItalyView further author information

Giuseppe Stinco3 Department of Medical and Biological Sciences, Dermatology Institute, Azienda Sanitaria Universitaria Friuli Centrale, Udine, ItalyView further author information

Luca Quartuccio1 Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy

https://orcid.org/0000-0002-0134-6439 View further author information

Enzo Errichetti3 Department of Medical and Biological Sciences, Dermatology Institute, Azienda Sanitaria Universitaria Friuli Centrale, Udine, ItalyCorrespondence[email protected]
View further author information

show all

References

Glintborg B, Di Giuseppe D, Wallman JK, et al. Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Ann Rheum Dis. 2023;82:820–828. doi:10.1136/ard-2022-223650
PubMed Web of Science ®Google Scholar
D’Agostino M-A, Boers M, Wakefield RJ, et al. Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting Abatacept: results from the APPRAISE study. RMD Open. 2016;2:e000237. doi:10.1136/rmdopen-2015-000237
PubMed Web of Science ®Google Scholar
Naredo E, D’Agostino MA, Wakefield RJ, et al. Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis. Ann Rheum Dis. 2013;72:1328–1334. doi:10.1136/annrheumdis-2012-202092
PubMed Web of Science ®Google Scholar
Balint PV, Terslev L, Aegerter P, et al. Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative. Ann Rheum Dis. 2018;77:1730–1735. doi:10.1136/annrheumdis-2018-213609
PubMed Web of Science ®Google Scholar
Perrotta FM, Scriffignano S, Ciccia F, Lubrano E. Clinical characteristics of potential ‘difficult-to-treat’ patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort. Rheumatol Ther. 2022;9:1193–1201. doi:10.1007/s40744-022-00461-w
PubMed Web of Science ®Google Scholar
Schoels MM, Aletaha D, Alasti F, Smolen JS. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811–818. doi:10.1136/annrheumdis-2015-207507
PubMed Web of Science ®Google Scholar
Mattei PL, Corey KC, Kimball AB. Psoriasis area severity index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014;28:333–337. doi:10.1111/jdv.12106
PubMed Web of Science ®Google Scholar

Bimekizumab in Biologics-Refractory Psoriatic Arthritis: A Real-Life Analysis from a Combined Dermatology-Rheumatology Clinic

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Bimekizumab in Biologics-Refractory Psoriatic Arthritis: A Real-Life Analysis from a Combined Dermatology-Rheumatology Clinic

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date